Company: CRVO
Filing Date: 2025-11-07
Form Type: S-8
Source: 0001437749-25-033900
Chunk: 0

Company: CervoMed Inc.
Filing Date: 2025-11-07
Form: S-8
Chunk 0
---
<div align='center'>As filed with the Securities and Exchange Commission on November 7, 2025</div>

Registration No. 333-

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION
<div align='center'>WASHINGTON, D.C. 20549

_________________

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

_________________

CervoMed Inc.

(Exact name of registrant as specified in its charter)

_________________</div>

| Delaware                        |     | 30-0645032         |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -IRS Employer      
 Identification No. |

<div align='center'>20 Park Plaza, Suite 424

Boston, MA 02116

(Address of Principal Executive Offices)

CervoMed Inc. 2025 Equity Incentive Plan

Non-Qualified Stock Option Inducement Awards

(Full title of the plan)

John Alam, M.D.

President & Chief Executive Officer

CervoMed Inc.

20 Park Plaza, Suite 424

Boston, MA 02116

(Name and address of agent for service)

(617) 744-4400

(Telephone number, including area code, of agent for service)

Copies to:

William C. Hicks

Jason S. McCaffrey

Mintz Levin Cohn Ferris Glovsky &

Popeo, P.C.

One Financial Center

Boston, MA 02111

(617) 542-6000</div>

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

| Large accelerated filer ☐ |     | Accelerated filer ☐         |
| Non-accelerated filer ☒   |     | Smaller reporting company ☒ |
|                           |     | Emerging growth company ☐   |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

<div align='center'>